Rituximab in combination with CHOP or fludarabine in low-grade lymphoma
- 1 February 2002
- journal article
- Published by Elsevier in Seminars in Oncology
- Vol. 29 (1) , 36-40
- https://doi.org/10.1053/sonc.2002.30152
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Treatment of Patients With Low-Grade B-Cell Lymphoma With the Combination of Chimeric Anti-CD20 Monoclonal Antibody and CHOP ChemotherapyJournal of Clinical Oncology, 1999
- Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic DrugsCancer Biotherapy & Radiopharmaceuticals, 1997
- Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.Journal of Clinical Oncology, 1996